| Intravitreal Anti-VEGF Drug Injections in Vitrectomized Eyes | HÜRKAN KERİMOĞLU | 307–313 |
| Evaluation of Central Corneal Thickness in Patients with Central and Hemi-central Retinal Vein Occlusion | Gülşah TALAY DAYANGAÇ,Seda KARACA ADIYEKE,İbrahim DAYANGAÇ,Neslişah KUTLU,Gamze TÜRE | 314–318 |
| Serum Vitamin D Levels in Patients with Age Related Macula Degeneration | Özkan KOCAMIŞ,RAŞİT KILIÇ,OSMAN AHMET POLAT,Ali KURT | 319–322 |
| Retina Ven Dal Tıkanıklığına Sekonder Gelişen Makula Ödeminde İntravitreal Afl ibercept ve Ranibizumab Karşılaştırması | Faruk KAYA,İbrahim KOÇAK,Ali AYDIN,Hakan BAYBORA,Hacı KOÇ,YUNUS KARABELA | 323–327 |
| Comparison of Intravitreal Afl ibercept and Ranibizumab for Macular Edema Secondary to Branch Retinal Vein Occlusion | Yunus KARABELA, Faruk KAYA, Hakan BAYBORA, İbrahim KOÇAK, Hacı KOÇ, Ali AYDIN | 323–327 |
| Ranibizumab Treatment in Exudative Age-Related Macular Rejeneration: Two Years Result | R.Büşra AKDAN BİLEN,Onur ÇATAK,Evin ŞİNGAR ÖZDEMİR,Orhan AYDEMİR,BURAK TURGUT,Ülkü ÇELİKER | 328–332 |
| Comparing Results of Intravitreal Afl ibercept and Ranibizumab Injections at Patients with Neovascular Age Related Macular Degeneration and Pigment Epithelial Detachment | Meltem Güzin ALTINEL,Ayşe YAĞMUR KANRA,Yelda BUYRU ÖZKURT | 333–339 |
| Retinal Ven Dal Tıkanıklığında Serum Endokan Seviyeleri Önemli mi? | Ali KURT,RAŞİT KILIÇ,RUKİYE NAR,Özkan KOCAMIŞ,OSMAN AHMET POLAT | 340–343 |
| Is Serum Endocan Levels Important in Branch Retinal Vein Occlusion? | Osman Ahmet POLAT, Rukiye NAR, Raşit KILIÇ, Özkan KOCAMIŞ, Ali KURT | 340–343 |
| The Prognostic Factors Affecting Anatomical and Functional Success in the Management of the Retinal Detachment with Giant Retinal Tears | Mustafa GÖK,V. Levent KARABAŞ,Fatih YENİHAYAT,SEVGİ SUBAŞI,Süleyman KARAMAN,Mehmet Ş. ASLAN | 344–350 |
| Use of Vitreon Tamponate in Inferior Rhegmatogeneus Retinal Detachment: Surgical Results and Complications | Hasan KIZILTOPRAK,Kemal TEKİN,MEHMET YASİN TEKE | 351–355 |